Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03355157 |
| Title | A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). (PADMA) |
| Acronym | PADMA |
| Recruitment | Completed |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | German Breast Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DEU |